Innovative Treatment: Rituximab-abbs Injection for Mucopolysaccharidosis III
Exploring the Role of Rituximab-abbs Injection in MPS III Treatment In recent years, the field of therapeutic advancements for Mucopolysaccharidosis III (MPS III) has seen a remarkable breakthrough with the introduction of Rituximab-abbs injection. This novel treatment approach is designed to target the underlying pathophysiology of this rare genetic disorder, characterized by a deficiency in […]